Evidence by expression analysis of candidate genes for congenital heart defects in the NF1 microdeletion interval

M. Venturin, A. Bentivegna, R. Moroni, L. Larizza, Paola Riva

Research output: Contribution to journalArticle

Abstract

It was recently reported that congenital heart disease is significantly more frequent in patients with NF1 microdeletion syndrome than in those with classical NF1. The outcome of congenital heart disease in this subset of patients is likely caused by the haploinsufficiency of gene/s in the deletion interval. Following in silico analysis of the deleted region, we found two genes known to be expressed in adult heart, the Joined to JAZF1 (SUZ12) and the Centaurin-alpha 2 (CENTA2) genes, and seven other genes with poorly defined patterns of expression and function. With the aim of defining their expression profiles in human fetal tissues (15th-21st weeks of gestation), expression analysis by RT-PCR and Northern blotting was performed. C17orf40, SUZ12 and CENTA2 were found to be mainly expressed in fetal heart, and following RT-PCR on mouse embryos and embryonic heart and brain at different stages of development, we found that the orthologous genes C17orf40, Suz12 and Centa2 are also expressed in early stages of development, before and during the formation of the four heart chambers. The presence of binding sites for Nkx2-5, a transcription factor expressed early in heart development, in all three mouse orthologous genes was predicted by bioinformatics, thus reinforcing the hypothesis that these genes might be involved in heart development and may be plausible candidates for congenital heart disease.

Original languageEnglish
Pages (from-to)508-516
Number of pages9
JournalAnnals of Human Genetics
Volume69
Issue number5
DOIs
Publication statusPublished - Sep 2005

Fingerprint

Congenital Heart Defects
Genetic Association Studies
Genes
Heart Diseases
Haploinsufficiency
Fetal Heart
Polymerase Chain Reaction
Computational Biology
Northern Blotting
Computer Simulation
Fetus
Transcription Factors
Embryonic Structures
Binding Sites
Pregnancy
Brain

Keywords

  • 17q11.2 genes
  • Congenital heart defects
  • Expression profile
  • Human fetal tissues
  • Mouse embryo

ASJC Scopus subject areas

  • Genetics
  • Genetics(clinical)

Cite this

Evidence by expression analysis of candidate genes for congenital heart defects in the NF1 microdeletion interval. / Venturin, M.; Bentivegna, A.; Moroni, R.; Larizza, L.; Riva, Paola.

In: Annals of Human Genetics, Vol. 69, No. 5, 09.2005, p. 508-516.

Research output: Contribution to journalArticle

Venturin, M. ; Bentivegna, A. ; Moroni, R. ; Larizza, L. ; Riva, Paola. / Evidence by expression analysis of candidate genes for congenital heart defects in the NF1 microdeletion interval. In: Annals of Human Genetics. 2005 ; Vol. 69, No. 5. pp. 508-516.
@article{f3c061a380fb4172a440f3b417fe8540,
title = "Evidence by expression analysis of candidate genes for congenital heart defects in the NF1 microdeletion interval",
abstract = "It was recently reported that congenital heart disease is significantly more frequent in patients with NF1 microdeletion syndrome than in those with classical NF1. The outcome of congenital heart disease in this subset of patients is likely caused by the haploinsufficiency of gene/s in the deletion interval. Following in silico analysis of the deleted region, we found two genes known to be expressed in adult heart, the Joined to JAZF1 (SUZ12) and the Centaurin-alpha 2 (CENTA2) genes, and seven other genes with poorly defined patterns of expression and function. With the aim of defining their expression profiles in human fetal tissues (15th-21st weeks of gestation), expression analysis by RT-PCR and Northern blotting was performed. C17orf40, SUZ12 and CENTA2 were found to be mainly expressed in fetal heart, and following RT-PCR on mouse embryos and embryonic heart and brain at different stages of development, we found that the orthologous genes C17orf40, Suz12 and Centa2 are also expressed in early stages of development, before and during the formation of the four heart chambers. The presence of binding sites for Nkx2-5, a transcription factor expressed early in heart development, in all three mouse orthologous genes was predicted by bioinformatics, thus reinforcing the hypothesis that these genes might be involved in heart development and may be plausible candidates for congenital heart disease.",
keywords = "17q11.2 genes, Congenital heart defects, Expression profile, Human fetal tissues, Mouse embryo",
author = "M. Venturin and A. Bentivegna and R. Moroni and L. Larizza and Paola Riva",
year = "2005",
month = "9",
doi = "10.1111/j.1529-8817.2005.00203.x",
language = "English",
volume = "69",
pages = "508--516",
journal = "Annals of Human Genetics",
issn = "0003-4800",
publisher = "Wiley-Blackwell",
number = "5",

}

TY - JOUR

T1 - Evidence by expression analysis of candidate genes for congenital heart defects in the NF1 microdeletion interval

AU - Venturin, M.

AU - Bentivegna, A.

AU - Moroni, R.

AU - Larizza, L.

AU - Riva, Paola

PY - 2005/9

Y1 - 2005/9

N2 - It was recently reported that congenital heart disease is significantly more frequent in patients with NF1 microdeletion syndrome than in those with classical NF1. The outcome of congenital heart disease in this subset of patients is likely caused by the haploinsufficiency of gene/s in the deletion interval. Following in silico analysis of the deleted region, we found two genes known to be expressed in adult heart, the Joined to JAZF1 (SUZ12) and the Centaurin-alpha 2 (CENTA2) genes, and seven other genes with poorly defined patterns of expression and function. With the aim of defining their expression profiles in human fetal tissues (15th-21st weeks of gestation), expression analysis by RT-PCR and Northern blotting was performed. C17orf40, SUZ12 and CENTA2 were found to be mainly expressed in fetal heart, and following RT-PCR on mouse embryos and embryonic heart and brain at different stages of development, we found that the orthologous genes C17orf40, Suz12 and Centa2 are also expressed in early stages of development, before and during the formation of the four heart chambers. The presence of binding sites for Nkx2-5, a transcription factor expressed early in heart development, in all three mouse orthologous genes was predicted by bioinformatics, thus reinforcing the hypothesis that these genes might be involved in heart development and may be plausible candidates for congenital heart disease.

AB - It was recently reported that congenital heart disease is significantly more frequent in patients with NF1 microdeletion syndrome than in those with classical NF1. The outcome of congenital heart disease in this subset of patients is likely caused by the haploinsufficiency of gene/s in the deletion interval. Following in silico analysis of the deleted region, we found two genes known to be expressed in adult heart, the Joined to JAZF1 (SUZ12) and the Centaurin-alpha 2 (CENTA2) genes, and seven other genes with poorly defined patterns of expression and function. With the aim of defining their expression profiles in human fetal tissues (15th-21st weeks of gestation), expression analysis by RT-PCR and Northern blotting was performed. C17orf40, SUZ12 and CENTA2 were found to be mainly expressed in fetal heart, and following RT-PCR on mouse embryos and embryonic heart and brain at different stages of development, we found that the orthologous genes C17orf40, Suz12 and Centa2 are also expressed in early stages of development, before and during the formation of the four heart chambers. The presence of binding sites for Nkx2-5, a transcription factor expressed early in heart development, in all three mouse orthologous genes was predicted by bioinformatics, thus reinforcing the hypothesis that these genes might be involved in heart development and may be plausible candidates for congenital heart disease.

KW - 17q11.2 genes

KW - Congenital heart defects

KW - Expression profile

KW - Human fetal tissues

KW - Mouse embryo

UR - http://www.scopus.com/inward/record.url?scp=24944554619&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=24944554619&partnerID=8YFLogxK

U2 - 10.1111/j.1529-8817.2005.00203.x

DO - 10.1111/j.1529-8817.2005.00203.x

M3 - Article

C2 - 16138909

AN - SCOPUS:24944554619

VL - 69

SP - 508

EP - 516

JO - Annals of Human Genetics

JF - Annals of Human Genetics

SN - 0003-4800

IS - 5

ER -